Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
21,180,198
-
Share change
-
+455,269
-
Total reported value
-
$820,096,834
-
Price per share
-
$38.72
-
Number of holders
-
87
-
Value change
-
+$17,273,238
-
Number of buys
-
50
-
Number of sells
-
37
Institutional Holders of DECIPHERA PHARMACEUTICALS IN - COM (DCPH) as of Q3 2018
As of 30 Sep 2018,
DECIPHERA PHARMACEUTICALS IN - COM (DCPH) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,180,198 shares.
The largest 10 holders included
New Leaf Venture Partners, L.L.C., ORBIMED ADVISORS LLC, SV Health Investors, LLC, Redmile Group, LLC, FMR LLC, Polar Capital LLP, Viking Global Investors LP, EMERALD ADVISERS INC/PA, JANUS HENDERSON GROUP PLC, and BlackRock Inc..
This page lists
87
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.